| Catalog Number |
ZBM10040 |
| Medical Device Problem Code |
Malposition of Device (2616)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/16/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H11: as the lot number for the device was provided, a review of the device history records was performed.The return of the sample is pending.The investigation of the reported event is currently underway.D2b (fge; nio).Section a through f: the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2026, a patient underwent stent placement procedure using e luminexx.During the deployment procedure the stent jumped and missed the targeted stenotic area in upper extremity.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent delivery system was not returned for evaluation and photos were not provided which leads to inconclusive results.In this case, only very limited information was provided about the event.Based on the provided information and as neither sample nor photos were provided for evaluation, the investigation is closed with a inconclusive results.A definitive root cause for the reported incident could not be identified.Labelling review: in reviewing the relevant labeling it was found that the instructions for use instruction for use (ifu) sufficiently address the potential risks the ifu contains a table describing the relationship between unconstrained stent diameter and reference lumen vessel diameter with regards to stent placement precautions the ifu states the stent experiences minimal length changes during deployment to maximize stent placement accuracy slowly and deliberately deploy the distal portion of the stent until you have visual confirmation of wall apposition before steadily deploying the remaining length of the stent regarding accessories the ifu state the bard safe 6f delivery system requires a minimum 6f introducer sheath insert a 0035 inch 089 mm guidewire regarding potential complications the ifu states stent malposition failure to deliver the stent to the intended site may occur d2b (fge; nio), g3, h6 (method, result, conclusion) section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2026, a patient underwent stent placement procedure using e luminexx.During the deployment procedure the stent jumped and missed the targeted stenotic area in upper extremity.There was no reported patient injury.
|
| |
|
Search Alerts/Recalls
|